Gain Therapeutics, Inc.

Nasdaq:GANX

Pharmaceutical Preparations·BETHESDA, MD

Governanceproxy statements · beneficial ownership

Proxy Statements

8 shown

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
4/17/25	PRE 14A	PRE 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
6/25/25	4	4	→
6/25/25	4	4	→
6/25/25	4	4	→
6/25/25	4	4	→
6/25/25	4	4	→
6/25/25	4	4	→
↓